LC
KALA icon

Lindbrook Capital’s KALA BIO KALA Stock Holding History

Lindbrook Capital’s Portfolio KALA Stock Details KALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-4
Closed -$26K – 2146
2021
Q3 		$26K Hold
4
– – 0.01% 654
2021
Q2 		$52K Buy
4
+2
+100% +$31.4K 0.01% 465
2021
Q1 		$36K Sell
2
-2
-50% -$39K 0.01% 551
2020
Q4 		$64K Buy
4
+1
+33% +$18.8K 0.02% 342
2020
Q3 		$48K Buy
3
+1
+50% +$23K 0.01% 370
2020
Q2 		$45K Sell
2
-3
-60% -$85K 0.01% 381
2020
Q1 		$99K Buy
+5
New +$79.9K 0.04% 187
2019
Q1 		– Sell
-2
Closed -$22K – 1450
2018
Q4 		$22K Buy
+2
New +$34.7K 0.01% 577

Other funds holding KALA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VAFP
Vahanian & Associates Financial Planning Saratoga Springs, New York $25.3M AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Lindbrook Capital's KALA Position: Q4 2021 in Review

Lindbrook Capital sold out of KALA BIO (KALA) in Q4 2021, closing a stake of 4 shares — an estimated $26K sold.

Lindbrook Capital first reported a position in KALA in Q4 2018 and held it in 8 quarters. The position peaked at $99K in Q1 2020. 79 funds tracked by Wall St. Rank hold KALA as of Q4 2021.

  • Lindbrook Capital reported no remaining KALA BIO position as of Q4 2021 after selling out during the quarter.
  • Lindbrook Capital sold 4 KALA BIO shares in Q4 2021, an estimated $26K.
  • Lindbrook Capital first reported a position in KALA BIO in Q4 2018 and held it in 8 quarters.
  • Lindbrook Capital's KALA BIO position peaked at $99K in Q1 2020.
  • 79 funds tracked by Wall St. Rank held KALA BIO as of Q4 2021.

Based on Lindbrook Capital's 13F filing for Q4 2021, filed 18 Jan 2022.